Indenone derivative and applications thereof as developing agent and aggregation inhibitor of amyloid protein deposit and neurofibrillary tangle
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- UNIV OF SCI & TECH OF CHINA
- Publication Date
- 2011-09-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to a new biologically active compound and its application, a method for diagnosis and treatment using a radioactive isotope or magnetic resonance contrast agent-labeled compound, and a preparation method for the labeled compound. Background technique
[0002] Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive aggravation. The main clinical manifestations are cognitive decline, irreversible memory loss, disorientation and language dysfunction. Brain tissue autopsy confirmed a large number of senile plaques (SPs) formed by amyloid-β (Aβ) peptide aggregation and many neurofibrillary tangles (neurofibrillary tangles) formed by filaments of hyperphosphorylated tau protein. NFTs), and the loss of neurons and synapses, etc., the amyloid deposits mentioned in the present invention include but are not limited to senile plaques.
[0003] Senile plaques and neurofibrillary tangles compose...